Articles by Suzanne Hodsden

  1. FDA Issues Guidance For HIV Prevention Drugs 11/25/2014

    A host of safe and effective HIV prevention drugs could be an invaluable tool in the fight against the spread of HIV/AIDS worldwide, but clinical research required to develop such products is a tricky terrain for scientists to navigate.

  2. Australia Uses Breast Cancer Research Strategies To Combat Ovarian Cancer 11/13/2014

    Ovarian Cancer Australia and the Peter McCallum Cancer Center have invested an initial $860K to revamp and refurbish efforts to research and develop treatments for ovarian cancer, according to ABC Australia.

  3. Obtaining FDA Approval For CNS Drugs Remains Industry Challenge, Study Finds 11/11/2014

    Tufts Center for the Study of Drug Development released a report, detailing their findings about the long and bumpy road central nervous system (CNS) drugs experience from discovery to FDA approval.

  4. Charles River Acquires ChanTest In $52M Deal 11/5/2014

    Charles River, a contract research organization (CRO) specializing in early development and discovery services, has acquired ChanTest in a $52M million deal.

  5. FDA Open For Suggestions For Improving Communication With IND Sponsors 11/4/2014

    The FDA published an announcement on the Register, seeking input from the public on how the agency might communicate better with pharma companies developing new drugs.

  6. Galapagos, Calchan Share Grant To Research Osteoarthritis 10/31/2014

    Innovate U.K. has awarded a $3.9 million grant for a new collaboration between Galapagos and Calchan, through which both parties will identify and develop new drug candidates to treat osteoarthritic pain.

  7. Experts: U.S. Falling Behind With Alzheimer's Goals 10/23/2014

    In 2011, President Obama signed into law The National Alzheimer’s Project Act (NAPA), which outlined a set of initiatives meant to find an effective treatment for Alzheimer’s disease by 2025. This week, research experts expressed concerns that the project was not proceeding as quickly as it should and proposed a list of fixes meant to strengthen and broaden the project with hopes of meeting original goals, ScienceDaily reports.

  8. U.K. Survey Finds Majority Would Enroll In Clinical Studies 10/22/2014

    The National Health Institute for Health Research Clinical Research Network (NIHR CRN) recently released the findings of a national survey, which found that 95 percent of those polled believed clinical research was a national healthcare priority.

  9. MedImmune In-Licenses Shionogi's Cardiovascular Biologic Program 10/16/2014

    MedImmune, the bio-technology arm of AstraZeneca, announced its acquisition of Shionogi’s preclinical cardiovascular biologic program, which could bring to the table a potential treatment for acute coronary syndrome (ACS).

  10. Can The Efficacy Of Potential Ebola Treatment Brincidofovir Match Its Clinical Advantages? 10/15/2014

    Chimerix’s Brincidofovir (CMX-001), a potentially broad-spectrum antiviral drug, made headlines last week when it was administered to two Ebola patients receiving treatment in the U.S. Though Thomas Duncan passed away in Dallas last week, Ashoka Mukpo reports signs of recovery, according to ABC.